Contact Us

Forecasting and Statistical Modeling

You Are Managing to a Threshold
That Does Not Exist Yet

Stars analytics built around the three things that actually determine the rating: where cut points are likely to land, how measure weighting changes the arithmetic, and how long each measure takes to move.
Cut points are set after the measurement period, from the performance of every other plan. Weights differ across measures and change between years. Some measures respond within months and others take two cycles. A programme that tracks current performance against last year thresholds is managing history, and it will allocate effort to measures that cannot change the rating.
The measure furthest from target is rarely the measure worth working. The one sitting on a cut point with a heavy weight usually is.
The Challenge

The rating you are looking at describes a year you cannot change

There is a long gap between the behaviour that produces a rating and the rating itself. The measurement period closes, the data is submitted, thresholds are calculated from the whole market, and the result arrives well after any of it could have been influenced. Meanwhile the plan is already accumulating performance for a future rating nobody is reporting on yet.
The structural consequence is that Stars work has to be forward-looking and probabilistic. Managing against published cut points is managing against a threshold that has already been superseded, and reporting current performance against last year target produces confidence that does not survive the next release.

Cut points are set retrospectively

They are derived from how every other plan performed. Identical performance in consecutive years can produce different ratings.

Weighting decides the arithmetic

A small movement on a heavily weighted measure can outperform a large movement on a light one. Effort allocated by gap size is misallocated by construction.

Measures move on different timescales

Adherence can respond within a cycle. Experience measures lag, are survey-based and cannot be fixed in-year.

Supplemental data determines clinical measure performance

Services delivered and not visible in claims do not count. A meaningful share of apparent quality failure is data capture rather than care.

Accountability is split and frequently unassigned

Pharmacy, clinical, member services, network and delegates each own parts of the rating, and very few plans have named an owner per measure.

The reporting is annual and the work is continuous

A measure reviewed quarterly against a stale threshold produces reaction. Continuous position estimation against a modelled range produces decisions.

And your current position is an estimate based on today evidence, not a result.

Claims arrive, clinical data changes, supplemental information is added and eligibility moves, so the analytical position shifts through the cycle even when nothing about care has changed.
Our Approach

Weight, proximity, reachability, time. In that order.

Prioritization in Stars is an arithmetic problem before it is a clinical one. Four factors determine whether working a measure changes the rating, and most programmes assess only one of them.

Step 1

Establish current position per measure from the plan own data rather than waiting for reported results, since reported results describe a closed period.

Step 2

Model the cut point as a distribution, informed by historical movement and market behaviour, rather than as last year published value.

Step 3

Calculate weighted rating impact per measure. What a realistic movement is worth given weight, proximity and the overall rating arithmetic.

Step 4

Assess reachability. Eligible population size, whether members can be contacted, and whether the intervention can complete within the period.

Step 5

Classify by time to impact, separating measures that can move this cycle from those requiring a longer horizon and different sponsorship.

Step 6

Separate care gaps from data gaps. Services delivered but not visible in claims are a supplemental data problem, not a clinical one.

Step 7

Assign an owner per measure. Pharmacy, clinical, member services, network or a delegate, with accountability written down.

Step 8

Build the member-level population with status per member: eligible, compliant, open gap, excluded, pending evidence, closed.

Step 9

Convert the forecast into a work plan. Determine how many additional compliant members are needed to reach target, whether they exist, are reachable, and whether time remains.

Step 10

Monitor continuously and re-forecast, since both your position and the likely threshold move through the year.

Some measures should be conceded deliberately.

Every plan has measures where the population is too small to move reliably, the weight is too low to matter, the threshold is too far, or the timescale is too long for the current cycle. Naming them as conceded for this cycle is uncomfortable, but it is a legitimate portfolio decision.
Capabilities

Forecasting, prioritization and the member-level work

Measure calculation is table stakes and most plans already have it. What changes the rating is forecasting the threshold, prioritizing by weighted impact, and turning a measure position into named members somebody can actually reach.

Know Your Position

Continuous Measure Calculation

Current performance per measure computed from plan data on an ongoing basis, with projected end-of-period position rather than a quarterly look at what already happened.

Cut Point Forecasting

Thresholds modelled as a distribution informed by historical movement, with probability stated rather than a single projected number.

Weighted Rating Simulation

The effect of realistic movement simulated against overall rating arithmetic.

Supplemental Data Completeness

Identify compliant services not visible in claims and where evidence exists but has not been captured.

Find the Work

Member-Level Gap Identification

Measure positions resolved to named members with the specific action required, deduplicated across measures.

Reachability and Segmentation

Which members can realistically be reached, through which channel, and where repeated contact has failed.

Medication Adherence Analytics

Fill gaps identified early enough to prevent a measure failure, with pharmacy and prescriber interventions.

Provider and Delegate Attribution

Which providers, groups and delegated entities influence which measures.

Manage the Portfolio

Prioritization and Scenario Modelling

Where to spend limited outreach and clinical capacity, with the effect on projected rating quantified and conceded measures named explicitly.

Intervention Effectiveness

Which interventions moved which measures for which populations.

Experience Measure Analytics

Drivers of member experience performance treated on their own timescale.

Performance and Completeness Monitored Together

Feed completeness, latency, matching and volume tracked alongside measure results.

Measure Governance

Specifications, versions and calculation logic maintained as versioned assets.

What CaliberFocus does, and does not do?

We do not run your outreach or your care management, and we will tell you when the constraint is capacity rather than targeting, because in that situation better analytics changes nothing. We will also recommend conceding measures, which is uncomfortable on a page selling quality improvement and is the correct portfolio answer. A plan working every measure equally is choosing not to prioritize, and that choice is usually invisible until the rating arrives.
Where It Applies

Measure families behave differently and should be managed differently

Grouping every measure into one improvement programme is the most common structural error in Stars work. These families differ in who influences them, how quickly they respond and what kind of intervention moves them, and the third column should determine how each is resourced.
Family Who influences it How it behaves
Medication adherence Pharmacy, prescribers, member services Among the most movable in-cycle. Fill gaps are predictable and preventable if seen early
Clinical process and screening Providers, care management, supplemental data capture Movable, and a large share of apparent failure is data capture rather than missing care
Chronic condition control Providers and care management Slower, requires clinical change, and results depend on documented values reaching the plan
Medication safety and appropriateness Pharmacy and prescribers Responsive to targeted prescriber intervention, and the eligible populations are usually small
Member experience The whole organization Heavily weighted, survey based, slow, and not addressable within the measurement year
Complaints, appeals and disenrollment Operations, member services, appeals Reflects operational performance months earlier. Fix the operation, not the measure
Care coordination and transitions Care management, network, delegates Requires provider and delegate engagement, so accountability has to be assigned outward

Adherence Is the Most Movable Measure Family You Have

Medication adherence responds to operational intervention within a cycle in a way most clinical measures do not. Fill gaps are visible in pharmacy data before they become failures, the members are identifiable, the intervention is well understood, and pharmacy and prescriber outreach both work. For most plans this is the highest-yield place to start.
The Method

Four questions decide whether a measure is worth working

Factor The question Why it disqualifies a measure
Weight How much does this measure contribute to the overall rating A large improvement on a light measure can be worth less than a marginal one elsewhere
Proximity How close are we to a likely cut point, expressed as a probability rather than a line Effort far from any threshold changes the rate and not the rating
Reachability Can we identify, contact and act on enough eligible members A measure with a small or unreachable population cannot move regardless of intent
Time to impact Can this measure respond within the period we are managing Experience and survey measures cannot be fixed in-cycle, however much attention they receive
Then Segment the Gaps That Remain
Measure-level prioritization decides where to spend. Gap-level segmentation decides what to do with each one.

Actionable now

A defined intervention can reasonably close it within the remaining period

Evidence pending

The care may have occurred and the supporting data has not arrived. Do not initiate outreach

Provider dependent

Closure requires provider documentation or action, so the intervention is provider engagement

Member dependent

Closure requires member engagement or behaviour, and reachability determines whether it is viable

Low probability

Technically open, realistically unrecoverable in the time remaining. Record it and move on

Analytical Discipline

Verify closure in the data the measure reads.

The gap between contacts made and gaps verified closed is the single most useful diagnostic in a Stars programme.
Integration

A large share of apparent quality failure is missing data

Claims show what was billed. Many quality measures require a result, a value or an assessment that a claim does not carry. Where that evidence exists in a provider record and never reaches the plan in a usable form, the measure records a failure and the care actually happened. Closing that gap is a data capture programme and it frequently outperforms any clinical intervention available.

Claims and encounters

Service evidence with final action resolved, since a reversed or adjusted claim should not count differently in a quality measure than it does in cost reporting.

 

Pharmacy data

Fill history and gaps, which is the most timely and operationally actionable signal available in Stars and underused as an early warning.

Clinical and supplemental sources

Laboratory results, values, assessments and provider-supplied data, with completeness monitored rather than assumed.

 

Member data

Contact information, language, channel preference and prior outreach history, since reachability determines whether any identified gap can be acted on.

Provider and delegate data

Attribution and relationship, so measure performance can be traced to the provider or delegated entity influencing it.

Survey and experience inputs

Treated on their own timescale, since these measures are heavily weighted and cannot be moved by the operational work that moves clinical measures.

Integration principles

Trust

A measure result feeds revenue and will be examined 

Stars performance drives revenue and public rating, which places measure calculation closer to regulated reporting than to management information. A result that cannot be reproduced, or a specification change that cannot be distinguished from a performance change, becomes a problem in a setting where explanation is expected.

Model governance

Validation

Explainability

Operational control

Outcomes

Rating impact, verified closure and capacity spent well

Stars programmes are usually reported on measure rates and outreach volume. Neither establishes that the rating will move or that a contact produced a verified closure.
Category What we measure Why it matters
Projected rating impact Modelled rating position with probability, and the contribution of each prioritized measure The only measure that reflects the outcome the plan is actually managing
Verified closure Gaps confirmed closed in the source the measure reads, against contacts made The gap between these two is how much outreach produced nothing
Capacity efficiency Verified closures per contact, and members addressed for multiple measures in one contact Outreach capacity is the binding constraint in most plans
Data gap recovery Compliant services made visible through supplemental data that were previously counted as failures Frequently the largest available improvement and it requires no clinical change
Adherence performance Fill gaps identified before failure, and the share prevented The most movable family, measured on prevention rather than on reporting
Equity Reach and verified closure by language, geography and population Whether the improvement is distributed or concentrated among the already-engaged

Two things are worth agreeing before starting.

A meaningful share of your apparent quality failure will turn out to be supplemental data capture rather than care, which requires a different programme than the one usually funded. And prioritization will recommend conceding measures, which is politically difficult in an organization where each measure has an advocate. Agree that the portfolio view governs before the analysis is produced, not after.

Improve stars performance with actionable quality intelligence

We will establish your current position from your own data, model where cut points are likely to land, calculate weighted rating impact per measure, and show you which measures are worth capacity this cycle and which are not. We will also test a sample of gaps to establish how much of your apparent failure is data capture rather than missing care, which frequently reframes the entire programme.

Start with the clinical workflow, not the ambient AI platform.

Bring us a specialty or clinical setting where clinicians are spending too much time creating notes. We will assess where ambient documentation fits, what must remain clinician controlled, how it should integrate with your EHR, and how to measure whether it is actually reducing burden.

One conversation with people who have run these deployments, and a written readiness view you can use with or without us.

Security & Compliance

caliberfocus certification

Ready to transform your business? Contact us today.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.